Optiver Holding’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,736
Closed -$182K 2430
2025
Q4
$182K Buy
+2,736
New +$177K ﹤0.01% 728
2025
Q3
Sell
-559
Closed -$48.8K 2742
2025
Q2
$48.8K Sell
559
-1,241
-69% -$97.3K ﹤0.01% 624
2025
Q1
$123K Buy
1,800
+1,379
+328% +$113K ﹤0.01% 438
2024
Q4
$32.7K Buy
+421
New +$31.2K ﹤0.01% 644
2024
Q3
Sell
-314
Closed -$35.6K 981
2024
Q2
$35.6K Buy
+314
New +$39.7K ﹤0.01% 590
2021
Q3
Sell
-292
Closed -$31K 741
2021
Q2
$31K Buy
+292
New +$28K ﹤0.01% 316

Other funds holding DXCM

Optiver Holding's DXCM Position: Q1 2026 in Review

Optiver Holding sold out of DexCom (DXCM) in Q1 2026, closing a stake of 2,736 shares — an estimated $182K sold.

Optiver Holding first reported a position in DXCM in Q2 2021 and held it in 6 quarters. The position peaked at $182K in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Optiver Holding reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Optiver Holding sold 2,736 DexCom shares in Q1 2026, an estimated $182K.
  • Optiver Holding first reported a position in DexCom in Q2 2021 and held it in 6 quarters.
  • Optiver Holding's DexCom position peaked at $182K in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.